Risk stratification for colorectal cancer and implications for screening

被引:0
|
作者
Tejpar, S [1 ]
机构
[1] Katholieke Univ Leuven, Ctr Human Genet, Dept Internal Med, Univ Hosp Gasthuisberg, B-3000 Louvain, Belgium
来源
ACTA GASTRO-ENTEROLOGICA BELGICA | 2005年 / 68卷 / 02期
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
In addition to the well-recognized syndromes described (FAP, HNPCC) clusters of colorectal cancers occur in families much more often than would be expected by chance. This familial clustering in about 10-20% of colorectal cancers has implications for screening because the immediate family members of a patient with apparent sporadic colorectal cancer have a twofold to threefold increased risk of the disease. The magnitude of the risk depends on the age at diagnosis of the index case, the degree of kinship of the index case to the at-risk case, and the number of affected relatives. In addition to screening the easily identifiable high-risk groups such as FAP and HNPCC, care should be taken to recognize intermediate-risk patients and to provide them with appropriate screening recommendations. Because the molecular basis and the natural history of these intermediate-risk patients are largely unknown, screening recommendations are as yet more empirical. If a person has a first degree relative with colon cancer, average risk colon cancer screening is recommended, but starting at age 40 years. The decreased age is given because the risk at age 40 for those with an affected first-degree relative is similar to the risk at age 50 for the general population. An individual with two first-degree relatives affected with colon cancer or one first-degree relative diagnosed under the age of 60 y should have colonoscopy beginning at age 40, or 10 years younger than the earliest case in the family. Colonoscopy should be repeated every five years if negative. An even stronger family history of colon cancer syndromes of colon cancer should suggest the consideration of one of the inherited syndromes..
引用
收藏
页码:241 / 242
页数:2
相关论文
共 50 条
  • [31] Correction: Risk stratification in prostate cancer screening
    Monique J. Roobol
    Sigrid V. Carlsson
    Nature Reviews Urology, 2013, 10 : 248 - 248
  • [32] Risk Stratification System for Oral Cancer Screening
    Pereira, Lutecia H. Mateus
    Reis, Isildinha M.
    Reategui, Erika P.
    Gordon, Claudia
    Saint-Victor, Sandra
    Duncan, Robert
    Gomez, Carmen
    Bayers, Stephanie
    Fisher, Penelope
    Perez, Aymee
    Goodwin, W. Jarrard
    Hu, Jennifer J.
    Franzmann, Elizabeth J.
    CANCER PREVENTION RESEARCH, 2016, 9 (06) : 445 - 455
  • [33] The Costs and Benefits of Risk Stratification for Colorectal Cancer Screening Based On Phenotypic and Genetic Risk: A Health Economic Analysis
    Thomas, Chloe
    Mandrik, Olena
    Saunders, Catherine L.
    Thompson, Deborah
    Whyte, Sophie
    Griffin, Simon
    Usher-Smith, Juliet A.
    CANCER PREVENTION RESEARCH, 2021, 14 (08) : 811 - 821
  • [34] Adenomas as a risk factor in familial colorectal cancer: implications for screening and surveillance in the UK
    Buczacki, S. J. A.
    Wheeler, J. M. D.
    COLORECTAL DISEASE, 2016, 18 (09) : 842 - 845
  • [35] The distribution of colorectal cancer in hereditary colorectal cancer syndromes and implications for screening
    Barrow, P. J.
    Newton, K.
    Lalloo, F.
    Hill, J.
    Evans, D. G.
    BRITISH JOURNAL OF SURGERY, 2013, 100 : 60 - 61
  • [36] Risk Stratification in the Context of Cancer Screening: Implications of Constraints on Strata-Specific Screening Policies for Efficiency and Equity
    Mahony, James F. O.
    MEDICAL DECISION MAKING, 2024, 44 (02) : NP7 - NP8
  • [37] Optimizing Colorectal Cancer Risk Stratification in the Colorectal Cancer Screening-Eligible 45-to 49-Year-Old Population
    Kamal, Yasmin
    Idos, Gregory E.
    GASTROENTEROLOGY, 2022, 163 (02) : 534 - 535
  • [38] Primary care colorectal cancer screening correlates with breast cancer screening: implications for colorectal cancer screening improvement interventions
    Weiss, Jennifer M.
    Pandhi, Nancy
    Kraft, Sally
    Potvien, Aaron
    Carayon, Pascale
    Smith, Maureen A.
    CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2018, 9
  • [39] Clinical implications of genomic evaluations for prostate cancer risk stratification, screening, and treatment: a narrative review
    Chung, Jae-Seung
    Morgan, Todd M.
    Hong, Sung Kyu
    PROSTATE INTERNATIONAL, 2020, 8 (03) : 99 - 106
  • [40] Histopathologic risk stratification of stage IIB colorectal cancer
    Komori, Koji
    Kinoshita, Takashi
    Oshiro, Taihei
    Ito, Seiji
    Abe, Tetsuya
    Senda, Yoshiki
    Misawa, Kazunari
    Ito, Yuichi
    Uemura, Norihisa
    Natsume, Seiji
    Kawakami, Jiro
    Ouchi, Akira
    Tsutsuyama, Masayuki
    Hosoi, Takahiro
    Shigeyoshi, Itaru
    Akazawa, Tomoyuk
    Hayashi, Daisuke
    Tanaka, Hideharu
    Shimizu, Yasuhiro
    SURGERY TODAY, 2017, 47 (08) : 934 - 939